BDNF and DYRK1A are variable and inversely correlated in lymphoblastoid cell lines from down syndrome patients

Asma Tlili, Alexander Hoischen, Clémentine Ripoll, Eva Benabou, Anne Badel, Anne Ronan, Renaud Touraine, Yann Grattau, Samantha Stora, Bregje Van Bon, Bert De Vries, Björn Menten, Nele Bockaert, Joseph Gecz, Stylianos E. Antonarakis, Dominique Campion, Marie Claude Potier, Henri Bléhaut, Jean Maurice Delabar, Nathalie Janel

Research output: Contribution to journalArticlepeer-review

16 Citations (Scopus)

Abstract

Down syndrome or trisomy 21 is the most common genetic disorder leading to mental retardation. One feature is impaired short- and long-term spatial memory, which has been linked to altered brain-derived neurotrophic factor (BDNF) levels. Mouse models of Down syndrome have been used to assess neurotrophin levels, and reduced BDNF has been demonstrated in brains of adult transgenic mice overexpressing Dyrk1a, a candidate gene for Down syndrome phenotypes. Given the link between DYRK1A overexpression and BDNF reduction in mice, we sought to assess a similar association in humans with Down syndrome. To determine the effect of DYRK1A overexpression on BDNF in the genomic context of both complete trisomy 21 and partial trisomy 21, we used lymphoblastoid cell lines from patients with complete aneuploidy of human chromosome 21 (three copies of DYRK1A) and from patients with partial aneuploidy having either two or three copies of DYRK1A. Decreased BDNF levels were found in lymphoblastoid cell lines from individuals with complete aneuploidy as well as those with partial aneuploidies conferring three DYRK1A alleles. In contrast, lymphoblastoid cell lines from individuals with partial trisomy 21 having only two DYRK1A copies displayed increased BDNF levels. A negative correlation was also detected between BDNF and DYRK1A levels in lymphoblastoid cell lines with complete aneuploidy of human chromosome 21. This finding indicates an upward regulatory role of DYRK1A expression on BDNF levels in lymphoblastoid cell lines and emphasizes the role of genetic variants associated with psychiatric disorders.

Original languageEnglish
Pages (from-to)297-303
Number of pages7
JournalMolecular Neurobiology
Volume46
Issue number2
DOIs
Publication statusPublished or Issued - Oct 2012
Externally publishedYes

Keywords

  • BDNF
  • DYRK1A
  • Down syndrome
  • Lymphoblastoid cell lines
  • Protein
  • mRNA

ASJC Scopus subject areas

  • Neurology
  • Cellular and Molecular Neuroscience

Cite this